Fensterheim, B. A. (2018). The TLR4 Agonist Monophosphoryl Lipid A Drives Broad Resistance to Infection via Dynamic Reprogramming of Macrophage Metabolism [INNATE IMMUNITY AND INFLAMMATION]. The American Association of Immunologists (AAI).
Chicago Style (17th ed.) CitationFensterheim, B. A. The TLR4 Agonist Monophosphoryl Lipid A Drives Broad Resistance to Infection via Dynamic Reprogramming of Macrophage Metabolism [INNATE IMMUNITY AND INFLAMMATION]. The American Association of Immunologists (AAI), 2018.
MLA (9th ed.) CitationFensterheim, B. A. The TLR4 Agonist Monophosphoryl Lipid A Drives Broad Resistance to Infection via Dynamic Reprogramming of Macrophage Metabolism [INNATE IMMUNITY AND INFLAMMATION]. The American Association of Immunologists (AAI), 2018.
Warning: These citations may not always be 100% accurate.